Bladder cancer is one of the most common cancers worldwide, with the majority of cases being diagnosed in older adults. According to global cancer statistics, there were approximately 550,000 new cases of bladder cancer diagnosed in 2020. The incidence of bladder cancer varies geographically, with higher rates reported in industrialized nations. Risk factors for bladder cancer include smoking, exposure to certain chemicals, chronic bladder inflammation, and family history.

TURBT

Transurethral resection of bladder tumor (TURBT) is a surgical procedure performed to diagnose and treat bladder tumors. The primary goals of TURBT are to obtain a tissue sample for pathological analysis and remove visible tumors while preserving bladder function.

During TURBT, the surgeon inserts a cystoscope through the urethra into the bladder. A resectoscope, equipped with a wire loop electrode, is then used to remove the tumor tissue layer by layer. The surgeon carefully navigates the instrument to ensure complete removal of visible tumors while minimizing damage to healthy bladder tissue. Additionally, any suspicious areas may be biopsied for further evaluation.

Recovery

Following TURBT, patients typically experience mild discomfort and urinary symptoms, such as urgency and frequency, which typically resolve within a few days. Most patients are discharged from the hospital on the same day or after a brief observation period. Some patients may have to go home with a urinary catheter to allow the bladder to heal. Full recovery may take several weeks, during which time patients are advised to avoid strenuous activities and follow any postoperative instructions provided by their healthcare team.

The above is only for medical information and does not constitute medical advice. Please contact your doctor if you have any questions.